WASHINGTON, March 10, 2026 (GLOBE NEWSWIRE) – Egg Medical, a leader in enhanced radiation protection devices (ERPD), today announced the results of a Late-Breaking Trial presented at the Cardiovascular Research Technologies (CRT) 2026 conference. The study, presented by Santiago Garcia, MD, of The Christ Hospital, confirms that the addition of the EggNest™ system reduces levels of scatter radiation to all members of the interventional team to the extent that users could do procedures safely without the use of lead aprons or wear ultralight aprons.
Press release
Staff dose with EggNest® presented as a late-breaking trial at CRT 2026
More news
Other announcements
-
21 October 2026
JAHA publishes The Christ Hospital study of EggNest, and Texas grants a radiation variance
Read the press release -
22 July 2026
Six societies call enhanced radiation protection mandatory, and their consensus statement names EggNest
Read the press release -
6 July 2026
EggNest Complete 2.0 debuts, with a lighter base and molded carbon fiber shields
Read the press release